Board approves preferential allotment of about Rs 139 crore to non-promoters

Fund Raising View source PDF Explain this filing

BPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.8%Reaction day

₹1955.00

prior close

₹1945.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-8.6% vs market

Pharmaceuticals peers, median of 172sector-0.9%-7.9% vs sector

On the reaction day the stock moved 8.6 pts less than Nifty Microcap 250 and 7.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-1.9

15m

-1.7

30m

-5.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.8-0.3-8.6-0.9-7.9

Next day

-10.6-1.5-9.0-1.6-8.9

-9.4-1.5-7.8-2.5-6.8

-3.8-0.2-3.6-1.3-2.6

-3.3-0.5-2.8-1.8-1.6

-3.3-3.2-0.1-3.5+0.2

-3.6-2.2-1.5-4.4+0.8

15d

-12.8-9.5-3.3-9.1-3.7

+5.1pendingpending-6.8+11.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bharat Parenterals board approved a preferential allotment of 9,12,759 equity shares at Rs 1,522.85 each, raising about Rs 139 crore from non-promoter investors. Allottees include WhiteOak Capital funds, Aurum Rising India Fund, Ashok India Equity Investment Trust PLC, India Acorn Fund, and a few individuals. EGM scheduled October 23, 2026 for shareholder approval.

Likely market impact

Equity dilution of about 12 percent; fresh capital for subsidiary investments. Share price may react based on issue price vs market price.